•Pipeline Report: Ready for a Return of the Blockbuster? Pharm Exec presents its annual overview of the most promising and novel new candidates in the battle to bring cutting-edge therapies to patients. Is the productivity lag finally over in time to bridge the patent cliff?

•Pharma Europe: A Leading Regulator Looks Back … and Ahead
Pharm Exec sits down with outgoing EMA Executive Director Thomas Lonngren to review his record and obtain some frank perspectives on industry and the future of the market authorization process in an era of tightening standards to show innovation.

•China – Still Fire in the Dragon
Our third-annual review of the booming China market focuses on tapping the emerging interior, making sense of comprehensive health reform, and tracing the growth of biotech.